Reports
Sale
Global Stem Cell Assay Market Size, Share, Growth, Report: By Product Type: Kits and Reagents, Instruments, Services; By Technology: Flow Cytometry, High-Content Screening, PCR, Spectrophotometry, Microarray, Other Technologies; By Assay Type; By Cell Type; By Application; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Stem Cell Assay Market Outlook
The global stem cell assay market size was valued at USD 6.4 billion in 2023, driven by the rising funding to conduct stem cell research activities across the globe. The market is expected to grow at a CAGR of 13.18% during the forecast period of 2024-2032, with the values likely to rise from USD 7.2 billion in 2024 to USD 19.4 billion by 2032.
Global Stem Cell Assay Market Overview
Stem cell assay is a laboratory technique utilized to assess the behaviour and properties of stem cells such as measuring their function. To study stem cell biology and investigate its potential therapeutic applications, stem cell assays are widely utilized across various sectors. The rising prevalence of chronic diseases such as cancer has increased the need for innovative therapies. With the global burden of new cancer cases predicted to reach approximately 30 million by 2040 , the stem cell assay market demand is expected to witness a surge in the coming years.
The market is experiencing a rising impetus for research and development activities in stem cell biology. Intensive research efforts are directed at utilizing stem cells in therapeutic applications, propelling the demand for stem cell assays. A study published in July 2023, revealed an innovative method to reverse cellular aging. The scientists involved in the study worked on expressing certain genes (Yamanaka factors) and converted adult cells into induced pluripotent stem cells (iPSCs). The researchers identified chemical cocktails that reverse cellular aging and restore youthful gene expression in less than a week without causing uncontrolled cell growth. Such developments led by robust research activities are estimated to fuel the stem cell assay market growth in the forecast period.
The market is also driven by the technological advancements in the sector resulting in improved efficiency and throughput of stem cell assays. Furthermore, the growing preference for personalized medicine and precision therapies will accelerate the market growth.
Global Stem Cell Assay Market Trends
| Key Trends | Description |
| Expansion of Stem Cell Applications | Growing applications in regenerative medicine and drug discovery are driving the demand for stem cell assays. |
| Technological Innovations in Assay Platforms | Rising advancements in screening and 3D culture technologies are expected to enhance the efficiency of assays and aid improved outcomes. |
| Regulatory and Ethical Frameworks | Development and standardization of global regulatory and ethical frameworks are influencing the stem cell assay market dynamics. |
| Increased Investment in Research and Development Activities | Increasing investment in research and development activities to meet diverse clinical needs is positively influencing the market size |
Global Stem Cell Assay Market Segmentation
Market Breakup by Product Type
- Kits and Reagents
- Instruments
- Services
The market is segmented by product type into kits and reagents, instruments, and services. Kits and reagents comprise consumables and chemical components required to conduct stem cell assays and facilitate cell culture. This segmentation reflects the diverse range of products and services in demand by the researchers and biopharmaceutical companies engaged in stem cell studies.
Market Breakup by Technology
- Flow Cytometry
- High-Content Screening
- PCR
- Spectrophotometry
- Microarray
- Other Technologies
The market breakup by technology in the global stem cell assay market includes flow cytometry, high-content screening, PCR (Polymerase Chain Reaction), spectrophotometry, microarray, and other technologies. These techniques are utilized in stem cell research and analysis and are expected to fuel the stem cell assay market size.
Market Breakup by Assay Type
- Viability/Cytotoxicity Assays
- Isolation/Purification Assays
- Differentiation Assays
- Proliferation Assays
- Apoptosis Assays
- Other Assay Types
By assay types, the market is divided into viability/cytotoxicity assays, isolation/purification assays, differentiation assays, proliferation assays, apoptosis assays, and other assay types. These assays are used to evaluate various aspects of stem cell biology.
Market Breakup by Cell Type
- Adult Stem Cells
- Embryonic Stem Cells
- Induced Pluripotent Stem Cells (iPSCs)
The market breakup by cell type includes adult stem cells, embryonic stem cells, and induced pluripotent stem cells (iPSCs). The market segment elucidates the diverse sources of stem cells needed in research and therapeutic applications.
Market Breakup by Application
- Drug Discovery and Development
- Regenerative Medicine and Therapy Development
- Clinical Research
- Other Applications
Major applications of the global stem cell assay market share include drug discovery and development, regenerative medicine and therapy development, clinical research, and other applications.
Market Breakup by End User
- Pharmaceutical and Biotechnology Companies
- Research Institutes
- Contract Research Organizations (CROs)
- Other End Users
End users of the market are pharmaceutical and biotechnology companies, research institutes, and contract research organizations (CROs), among others. Pharmaceutical and biotechnology companies hold a significant market share in the segment, utilizing stem cell assays in drug discovery, development, and testing.
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The market breakup by region includes North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America is a major market which can be attributed to the significant investments in research and development by various sectors, advanced healthcare infrastructure, and growing demand for personalized medicines.
Global Stem Cell Assay Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific Inc.
- Merck KGaA (Sigma-Aldrich)
- PerkinElmer, Inc.
- GE Healthcare
- Bio-Rad Laboratories, Inc.
- STEMCELL Technologies Inc.
- Cell Biolabs, Inc.
- Promega Corporation
- Lonza Group
- Miltenyi Biotec
- Cell Signaling Technology, Inc.
- Agilent Technologies, Inc.
- R&D Systems (a Bio-Techne brand)
- Bio-Techne Corporation
- Cytiva (formerly GE Healthcare Life Sciences)
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Technology |
|
| Breakup by Assay Type |
|
| Breakup by Cell Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Key Queries Solved in the Global Stem Cell Assay Market Report
- How is the market landscape expected to evolve in the forecast period?
- What future trends are be anticipated for the market?
- Which regional market is dominating the market share?
- Which regional market is expected to experience expedited growth during the forecast period?
- Which stem cell assay technology will dominate the market share?
- Which cell type in the market segment will experience a significant demand in the coming years?
- What are the key research initiatives expected to boost the market size during the forecast period?
- What stem cell assay types are expected to lead the market segment?
- Which application is poised to make the highest impact on the stem cell assay market value?
- What are the market shares, strategies, and product portfolios of the leading players in the market?
- How is the regulatory landscape shaping the neonatal ventilators market?
- What are the market dynamics, trends, and growth prospects in the key regional markets?
- What are the unmet needs of customers in the market?
- How is technology innovation in stem cell assays impacting the development of stem cell research?
- What are the investment opportunities and potential risks associated with the market?
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Stem Cell Assay Market Overview
3.1 Global Stem Cell Assay Market Historical Value (2017-2023)
3.2 Global Stem Cell Assay Market Forecast Value (2024-2032)
4 Global Stem Cell Assay Market Landscape*
4.1 Global Stem Cell Assay: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Stem Cell Assay: Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Technology
5 Global Stem Cell Assay Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Stem Cell Assay Market Segmentation (2017-2032)
6.1 Global Stem Cell Assay Market (2017-2032) by Product Type
6.1.1 Market Overview
6.1.2 Kits and Reagents
6.1.3 Instruments
6.1.4 Services
6.2 Global Stem Cell Assay Market (2017-2032) by Technology
6.2.1 Market Overview
6.2.2 Flow Cytometry
6.2.3 High-Content Screening
6.2.4 PCR
6.2.5 Spectrophotometry
6.2.6 Microarray
6.2.7 Other Technologies
6.3 Global Stem Cell Assay Market (2017-2032) by Assay Type
6.3.1 Market Overview
6.3.2 Viability/Cytotoxicity Assays
6.3.3 Isolation/Purification Assays
6.3.4 Differentiation Assays
6.3.5 Proliferation Assays
6.3.6 Apoptosis Assays
6.3.7 Other Assay Types
6.4 Global Stem Cell Assay Market (2017-2032) by Cell Type
6.4.1 Market Overview
6.4.2 Adult Stem Cells
6.4.3 Embryonic Stem Cells
6.4.4 Induced Pluripotent Stem Cells (iPSCs)
6.5 Global Stem Cell Assay Market (2017-2032) by Application
6.5.1 Market Overview
6.5.2 Drug Discovery and Development
6.5.3 Regenerative Medicine and Therapy Development
6.5.4 Clinical Research
6.5.5 Other Applications
6.6 Global Stem Cell Assay Market (2017-2032) by End User
6.6.1 Market Overview
6.6.2 Pharmaceutical and Biotechnology Companies
6.6.3 Research Institutes
6.6.4 Contract Research Organizations (CROs)
6.6.5 Other End Users
6.7 Global Stem Cell Assay Market (2017-2032) by Region
6.7.1 Market Overview
6.7.2 North America
6.7.3 Europe
6.7.4 Asia Pacific
6.7.5 Latin America
6.7.6 Middle East and Africa
7 North America Stem Cell Assay Market (2017-2032)
7.1 North America Stem Cell Assay Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 Kits and Reagents
7.1.3 Instruments
7.1.4 Services
7.2 North America Stem Cell Assay Market (2017-2032) by Technology
7.2.1 Market Overview
7.2.2 Flow Cytometry
7.2.3 High-Content Screening
7.2.4 PCR
7.2.5 Spectrophotometry
7.2.6 Microarray
7.2.7 Other Technologies
7.3 North America Stem Cell Assay Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Stem Cell Assay Market (2017-2032)
8.1 Europe Stem Cell Assay Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 Kits and Reagents
8.1.3 Instruments
8.1.4 Services
8.2 Europe Stem Cell Assay Market (2017-2032) by Technology
8.2.1 Market Overview
8.2.2 Flow Cytometry
8.2.3 High-Content Screening
8.2.4 PCR
8.2.5 Spectrophotometry
8.2.6 Microarray
8.2.7 Other Technologies
8.3 Europe Stem Cell Assay Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Stem Cell Assay Market (2017-2032)
9.1 Asia Pacific Stem Cell Assay Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 Kits and Reagents
9.1.3 Instruments
9.1.4 Services
9.2 Asia Pacific Stem Cell Assay Market (2017-2032) by Technology
9.2.1 Market Overview
9.2.2 Flow Cytometry
9.2.3 High-Content Screening
9.2.4 PCR
9.2.5 Spectrophotometry
9.2.6 Microarray
9.2.7 Other Technologies
9.3 Asia Pacific Stem Cell Assay Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Stem Cell Assay Market (2017-2032)
10.1 Latin America Stem Cell Assay Market (2017-2032) by Product Type
10.1.1 Market Overview
10.1.2 Kits and Reagents
10.1.3 Instruments
10.1.4 Services
10.2 Latin America Stem Cell Assay Market (2017-2032) by Technology
10.2.1 Market Overview
10.2.2 Flow Cytometry
10.2.3 High-Content Screening
10.2.4 PCR
10.2.5 Spectrophotometry
10.2.6 Microarray
10.2.7 Other Technologies
10.3 Latin America Stem Cell Assay Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Stem Cell Assay Market (2017-2032)
11.1 Middle East and Africa Stem Cell Assay Market (2017-2032) by Product Type
11.1.1 Market Overview
11.1.2 Kits and Reagents
11.1.3 Instruments
11.1.4 Services
11.2 Middle East and Africa Stem Cell Assay Market (2017-2032) by Technology
11.2.1 Market Overview
11.2.2 Flow Cytometry
11.2.3 High-Content Screening
11.2.4 PCR
11.2.5 Spectrophotometry
11.2.6 Microarray
11.2.7 Other Technologies
11.3 Middle East and Africa Stem Cell Assay Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Thermo Fisher Scientific Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Merck KGaA (Sigma-Aldrich)
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 PerkinElmer, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 GE Healthcare
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Bio-Rad Laboratories, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 STEMCELL Technologies Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Cell Biolabs, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Promega Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Lonza Group
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Miltenyi Biotec
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Cell Signaling Technology, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Agilent Technologies, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 R&D Systems (a Bio-Techne brand)
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Bio-Techne Corporation
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Cytiva (formerly GE Healthcare Life Sciences)
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
List not exhaustive
18 Global Stem Cell Assay Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market attained a value of about USD 6.4 billion in 2023 driven by the rising funding in stem cell research across the globe.
The market is anticipated to grow at a CAGR of 13.18% during the forecast period of 2024-2032, likely to reach a market value of USD 19.4 billion by 2032.
Technological advancements in stem cell assay techniques such as the development of high-output screening platforms and 3D cell culture techniques are fuelling the demand for the market.
One of the significant trends in the market is the increased research and development activities in stem cell biology. In July 2023, a study published in the biomedical journal discovered a way to reverse cellular aging. The study was based on expressing certain genes (Yamanaka factors), and converting adult cells into induced pluripotent stem cells (iPSCs).
Based on the product type, the market is segmented into kits and reagents, instruments, and services.
Technologies available in the market include flow cytometry, high-content screening, PCR (polymerase chain reaction), spectrophotometry, microarray, and other technologies.
By assay types, the market is divided into viability/cytotoxicity assays, isolation/purification assays, differentiation assays, proliferation assays, apoptosis assays, and other assay types.
The market breakup by cell type includes adult stem cells, embryonic stem cells, and induced pluripotent stem cells (iPSCs).
End users of the market are pharmaceutical and biotechnology companies, research institutes, and contract research organizations (CROs), among others.
Major applications areas of stem cell assay include drug discovery and development, regenerative medicine and therapy development, clinical research, and other applications.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
Key players involved in the market are Thermo Fisher Scientific Inc., Merck KGaA (Sigma-Aldrich), PerkinElmer, Inc., GE Healthcare, Bio-Rad Laboratories, Inc., STEMCELL Technologies Inc., Cell Biolabs, Inc., Promega Corporation, Lonza Group, Miltenyi Biotec, Cell Signaling Technology, Inc., Agilent Technologies, Inc., R&D Systems (a Bio-Techne brand), Bio-Techne Corporation, and Cytiva (formerly GE Healthcare Life Sciences).
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER